ALMDT 📈 Mediantechn - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0011049824
ALMDT: Medical, Imaging, Analysis, Software, AI, Diagnostic
Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, France. Web URL: https://www.mediantechnologies.com
Additional Sources for ALMDT Stock
ALMDT Stock Overview
| Market Cap in USD | 62m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Health Care Technology |
| IPO / Inception |
ALMDT Stock Ratings
| Growth 5y | 17.9% |
| Fundamental | 3.54% |
| Dividend | - |
| Rel. Strength Industry | -1348 |
| Analysts | - |
| Fair Price Momentum | 3.14 EUR |
| Fair Price DCF | - |
ALMDT Dividends
No Dividends PaidALMDT Growth Ratios
| Growth Correlation 3m | -66.5% |
| Growth Correlation 12m | 15.4% |
| Growth Correlation 5y | -27.5% |
| CAGR 5y | 13.75% |
| CAGR/Mean DD 5y | 0.32 |
| Sharpe Ratio 12m | 0.16 |
| Alpha | -48.12 |
| Beta | 0.88 |
| Volatility | 81.43% |
| Current Volume | 33.7k |
| Average Volume 20d | 63.9k |
What is the price of ALMDT stocks?
As of December 22, 2024, the stock is trading at EUR 3.67 with a total of 33,678 shares traded.
Over the past week, the price has changed by +2.03%, over one month by -8.69%, over three months by -12.00% and over the past year by -29.10%.
As of December 22, 2024, the stock is trading at EUR 3.67 with a total of 33,678 shares traded.
Over the past week, the price has changed by +2.03%, over one month by -8.69%, over three months by -12.00% and over the past year by -29.10%.
Is Mediantechn a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Mediantechn is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.54 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALMDT as of December 2024 is 3.14. This means that ALMDT is currently overvalued and has a potential downside of -14.44%.
Neither. Based on ValueRay Fundamental Analyses, Mediantechn is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.54 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALMDT as of December 2024 is 3.14. This means that ALMDT is currently overvalued and has a potential downside of -14.44%.
Is ALMDT a buy, sell or hold?
Mediantechn has no consensus analysts rating.
Mediantechn has no consensus analysts rating.
What are the forecast for ALMDT stock price target?
According to ValueRays Forecast Model, ALMDT Mediantechn will be worth about 3.4 in December 2025. The stock is currently trading at 3.67. This means that the stock has a potential downside of -7.63%.
According to ValueRays Forecast Model, ALMDT Mediantechn will be worth about 3.4 in December 2025. The stock is currently trading at 3.67. This means that the stock has a potential downside of -7.63%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 16.2 | 342.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 3.4 | -7.6% |